FI891491A - Omaettade n-benzopyranyllaktamer. - Google Patents
Omaettade n-benzopyranyllaktamer. Download PDFInfo
- Publication number
- FI891491A FI891491A FI891491A FI891491A FI891491A FI 891491 A FI891491 A FI 891491A FI 891491 A FI891491 A FI 891491A FI 891491 A FI891491 A FI 891491A FI 891491 A FI891491 A FI 891491A
- Authority
- FI
- Finland
- Prior art keywords
- omaettade
- benzopyranyllaktamer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
- C07C317/42—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3811017A DE3811017A1 (de) | 1988-03-31 | 1988-03-31 | Ungesaettigte n-benzopyranyllactame |
Publications (2)
Publication Number | Publication Date |
---|---|
FI891491A0 FI891491A0 (fi) | 1989-03-29 |
FI891491A true FI891491A (fi) | 1989-10-01 |
Family
ID=6351175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI891491A FI891491A (fi) | 1988-03-31 | 1989-03-29 | Omaettade n-benzopyranyllaktamer. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5043344A (fi) |
EP (1) | EP0337179A1 (fi) |
JP (1) | JPH01287083A (fi) |
KR (1) | KR890014526A (fi) |
AU (1) | AU615275B2 (fi) |
DE (1) | DE3811017A1 (fi) |
DK (1) | DK155489A (fi) |
FI (1) | FI891491A (fi) |
HU (1) | HU203341B (fi) |
IL (1) | IL89778A (fi) |
NO (1) | NO891346L (fi) |
NZ (1) | NZ228511A (fi) |
PH (1) | PH25959A (fi) |
PT (1) | PT90172A (fi) |
ZA (1) | ZA892307B (fi) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5387587A (en) * | 1986-12-23 | 1995-02-07 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Chroman derivatives |
DE3726261A1 (de) * | 1986-12-23 | 1988-07-07 | Merck Patent Gmbh | Chromanderivate |
US5284838A (en) * | 1987-06-23 | 1994-02-08 | Elf Sanofi | Use of 2,2-dimethylchroman-3-ol derivatives in the treatment of asthma |
WO1989010925A1 (en) * | 1988-05-09 | 1989-11-16 | Beecham Group Plc | Novel compounds and treatment |
DE3837809A1 (de) * | 1988-11-08 | 1990-05-10 | Merck Patent Gmbh | Tetralinderivate |
DE3923839A1 (de) * | 1989-07-19 | 1991-01-31 | Beiersdorf Ag | Benzopyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen |
GB8916683D0 (en) * | 1989-07-21 | 1989-09-06 | Beecham Group Plc | Novel compounds |
DE3924417A1 (de) * | 1989-07-24 | 1991-01-31 | Merck Patent Gmbh | Chromanderivate |
DE3936616A1 (de) * | 1989-11-03 | 1991-05-08 | Merck Patent Gmbh | Verfahren zur enantiomerentrennung von benzopyranderivaten |
EP0430621A3 (en) * | 1989-11-29 | 1992-03-04 | Beecham Group P.L.C. | Process for the preparation of chiral 3,4-epoxy benzopyrans |
WO1991009031A1 (en) * | 1989-12-11 | 1991-06-27 | Beecham Group Plc | Trifluoromethyl substituted compounds and a pharmaceutical composition |
TW257762B (fi) * | 1991-06-14 | 1995-09-21 | Nippon Chemicals Pharmaceutical Co Ltd | |
FI930148A (fi) * | 1992-01-18 | 1993-07-19 | Hoechst Ag | Foerfarande foer enantioselektiv epoxidation av i 6-staellning substituerade kromener |
HUT72741A (en) * | 1992-12-19 | 1996-05-28 | Alkaloida Vegyeszeti Gyar | Method for producing benzopyrane derivatives and pharmaceutical compositions containing them |
IL108841A0 (en) * | 1993-03-10 | 1994-06-24 | Pfizer Res & Dev | Benzopyrans |
GB9316111D0 (en) * | 1993-08-04 | 1993-09-22 | Pfizer Ltd | Benzopyrans |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3274350D1 (en) * | 1981-09-25 | 1987-01-08 | Beecham Group Plc | Pharmaceutically active benzopyran compounds |
EP0091748B1 (en) * | 1982-04-08 | 1986-06-18 | Beecham Group Plc | Antihypertensive benzopyranols |
GB8308062D0 (en) * | 1983-03-24 | 1983-05-05 | Beecham Group Plc | Active compounds |
DE3726261A1 (de) * | 1986-12-23 | 1988-07-07 | Merck Patent Gmbh | Chromanderivate |
AU618007B2 (en) * | 1987-06-23 | 1991-12-12 | Sanofi | 2,2-dimethylchroman-3-ol derivatives, process for their preparation and pharmaceutical compositions in which they are present |
US4997846A (en) * | 1988-12-09 | 1991-03-05 | Researche Syntex France, S.A. | Novel benzopyranylpyrrolinone derivatives |
-
1988
- 1988-03-31 DE DE3811017A patent/DE3811017A1/de not_active Withdrawn
-
1989
- 1989-03-25 EP EP89105352A patent/EP0337179A1/de not_active Withdrawn
- 1989-03-28 IL IL89778A patent/IL89778A/xx unknown
- 1989-03-29 PH PH38397A patent/PH25959A/en unknown
- 1989-03-29 US US07/330,042 patent/US5043344A/en not_active Expired - Fee Related
- 1989-03-29 NZ NZ228511A patent/NZ228511A/en unknown
- 1989-03-29 ZA ZA892307A patent/ZA892307B/xx unknown
- 1989-03-29 FI FI891491A patent/FI891491A/fi not_active Application Discontinuation
- 1989-03-30 JP JP1076867A patent/JPH01287083A/ja active Pending
- 1989-03-30 AU AU32244/89A patent/AU615275B2/en not_active Ceased
- 1989-03-30 KR KR1019890004032A patent/KR890014526A/ko not_active Application Discontinuation
- 1989-03-30 NO NO89891346A patent/NO891346L/no unknown
- 1989-03-30 PT PT90172A patent/PT90172A/pt not_active Application Discontinuation
- 1989-03-30 DK DK155489A patent/DK155489A/da not_active Application Discontinuation
- 1989-08-08 HU HU891576A patent/HU203341B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU3224489A (en) | 1989-10-05 |
US5043344A (en) | 1991-08-27 |
IL89778A0 (en) | 1989-09-28 |
HU203341B (en) | 1991-07-29 |
EP0337179A1 (de) | 1989-10-18 |
NZ228511A (en) | 1991-09-25 |
AU615275B2 (en) | 1991-09-26 |
DE3811017A1 (de) | 1989-10-19 |
JPH01287083A (ja) | 1989-11-17 |
ZA892307B (en) | 1989-11-29 |
NO891346D0 (no) | 1989-03-30 |
IL89778A (en) | 1993-07-08 |
PT90172A (pt) | 1989-11-10 |
KR890014526A (ko) | 1989-10-24 |
NO891346L (no) | 1989-10-02 |
DK155489A (da) | 1989-10-01 |
DK155489D0 (da) | 1989-03-30 |
FI891491A0 (fi) | 1989-03-29 |
PH25959A (en) | 1992-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68906637D1 (de) | Wafertraeger. | |
FI886051A (fi) | Reglerventil. | |
FI894261A0 (fi) | Vattenbestaendig kraem. | |
FI893266A0 (fi) | Biarylfoereningar. | |
FI885411A (fi) | Ljusbestraolningsapparat foer medicinskt bruk. | |
DE68921898D1 (de) | Ringbinder. | |
DE68903708D1 (de) | Spielkasten. | |
FI891491A0 (fi) | Omaettade n-benzopyranyllaktamer. | |
DE68909215D1 (de) | Laseroszillator. | |
DE58902190D1 (de) | Schaelmaschine. | |
NO894091D0 (no) | Luftstoet-stoepemaskin. | |
FI894625A0 (fi) | Skoinnersula. | |
DE58900554D1 (de) | Aminoguanidinoazine. | |
FI83400B (fi) | Faestningsklaemma. | |
FI80861B (fi) | Plastdosa. | |
ATE86241T1 (de) | Indanderivate. | |
FI892360A (fi) | Hopfaellbar hydraulisk gruvstoetta. | |
FI893591A0 (fi) | Stereoselektivt oxidationsfoerfarande. | |
ATE82110T1 (de) | Magensonde. | |
ES1005477Y (es) | Braga-compresa. | |
ES1013066Y (es) | Cantonera. | |
DE68907005D1 (de) | Octafluorbiphenyle. | |
ES1008248Y (es) | Billar-bolera. | |
DE68905805D1 (de) | Cyclopentano-vitamin d-analoge. | |
ES1004162Y (es) | Salero-pimentero. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
FD | Application lapsed |
Owner name: HOECHST AKTIENGESELLSCHAFT |